149 related articles for article (PubMed ID: 23777370)
1. The study of pH-dependent stability shows that the TPLH-mediated hydrogen-bonding network is important for the conformation and stability of human gankyrin.
Yuan C; Guo Y; Zhu L; Guo W; Mahajan A; Weghorst CM; Li J
Biochemistry; 2013 Jul; 52(28):4848-57. PubMed ID: 23777370
[TBL] [Abstract][Full Text] [Related]
2. Contributions of conserved TPLH tetrapeptides to the conformational stability of ankyrin repeat proteins.
Guo Y; Yuan C; Tian F; Huang K; Weghorst CM; Tsai MD; Li J
J Mol Biol; 2010 May; 399(1):168-81. PubMed ID: 20398677
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship.
Yuan C; Li J; Mahajan A; Poi MJ; Byeon IJ; Tsai MD
Biochemistry; 2004 Sep; 43(38):12152-61. PubMed ID: 15379554
[TBL] [Abstract][Full Text] [Related]
4. Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16.
Mahajan A; Guo Y; Yuan C; Weghorst CM; Tsai MD; Li J
J Mol Biol; 2007 Nov; 373(4):990-1005. PubMed ID: 17881001
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of the conformational stability of cyclin-dependent kinase (CDK) 4-interacting ankyrin repeat (AR) proteins.
Guo Y; Mahajan A; Yuan C; Joo SH; Weghorst CM; Tsai MD; Li J
Biochemistry; 2009 May; 48(19):4050-62. PubMed ID: 19320462
[TBL] [Abstract][Full Text] [Related]
6. Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome.
Nakamura Y; Nakano K; Umehara T; Kimura M; Hayashizaki Y; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S
Structure; 2007 Feb; 15(2):179-89. PubMed ID: 17292836
[TBL] [Abstract][Full Text] [Related]
7. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53.
Krzywda S; Brzozowski AM; Higashitsuji H; Fujita J; Welchman R; Dawson S; Mayer RJ; Wilkinson AJ
J Biol Chem; 2004 Jan; 279(2):1541-5. PubMed ID: 14573599
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Proteins Potently and Selectively Bind the Oncoprotein Gankyrin, Modulate Its Interaction with S6 ATPase, and Suppress Gankyrin/MDM2-Dependent Ubiquitination of p53.
Chapman AM; McNaughton BR
ACS Chem Biol; 2015 Aug; 10(8):1880-6. PubMed ID: 25955581
[TBL] [Abstract][Full Text] [Related]
9. Discovery of multiple interacting partners of gankyrin, a proteasomal chaperone and an oncoprotein--evidence for a common hot spot site at the interface and its functional relevance.
Nanaware PP; Ramteke MP; Somavarapu AK; Venkatraman P
Proteins; 2014 Jul; 82(7):1283-300. PubMed ID: 24338975
[TBL] [Abstract][Full Text] [Related]
10. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J
Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of Rb and CDK4/6.
Padmanabhan B; Adachi N; Kataoka K; Horikoshi M
J Biol Chem; 2004 Jan; 279(2):1546-52. PubMed ID: 14583612
[TBL] [Abstract][Full Text] [Related]
12. Mutation of conserved histidines alters tertiary structure and nanomechanics of consensus ankyrin repeats.
Lee W; Strümpfer J; Bennett V; Schulten K; Marszalek PE
J Biol Chem; 2012 Jun; 287(23):19115-21. PubMed ID: 22514283
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of human oncoprotein gankyrin in Zebrafish.
Kim SY; Hur W; Choi JE; Kim D; Wang JS; Yoon HY; Piao LS; Yoon SK
Exp Mol Med; 2009 Jan; 41(1):8-16. PubMed ID: 19287195
[TBL] [Abstract][Full Text] [Related]
15. Characterizing a partially folded intermediate of the villin headpiece domain under non-denaturing conditions: contribution of His41 to the pH-dependent stability of the N-terminal subdomain.
Grey MJ; Tang Y; Alexov E; McKnight CJ; Raleigh DP; Palmer AG
J Mol Biol; 2006 Feb; 355(5):1078-94. PubMed ID: 16332376
[TBL] [Abstract][Full Text] [Related]
16. A site-directed mutagenesis study of the MdmX RING domain.
Egorova O; Mis M; Sheng Y
Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
[TBL] [Abstract][Full Text] [Related]
17. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.
Higashitsuji H; Liu Y; Mayer RJ; Fujita J
Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the recognition between the regulatory particles Nas6 and Rpt3 of the yeast 26S proteasome.
Nakamura Y; Umehara T; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S
Biochem Biophys Res Commun; 2007 Aug; 359(3):503-9. PubMed ID: 17555716
[TBL] [Abstract][Full Text] [Related]
19. Mechanical unfolding of an ankyrin repeat protein.
Serquera D; Lee W; Settanni G; Marszalek PE; Paci E; Itzhaki LS
Biophys J; 2010 Apr; 98(7):1294-301. PubMed ID: 20371329
[TBL] [Abstract][Full Text] [Related]
20. Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation.
Wei SJ; Williams JG; Dang H; Darden TA; Betz BL; Humble MM; Chang FM; Trempus CS; Johnson K; Cannon RE; Tennant RW
J Mol Biol; 2008 Nov; 383(3):693-712. PubMed ID: 18775730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
